Integra LifeSciences Holdings Corporation (IART): Price and Financial Metrics

Integra LifeSciences Holdings Corporation (IART): $41.27

0.04 (-0.10%)

POWR Rating

Component Grades








IART Price/Volume Stats

Current price $41.27 52-week high $60.69
Prev. close $41.31 52-week low $33.44
Day low $40.72 Volume 286,300
Day high $41.38 Avg. volume 621,711
50-day MA $38.24 Dividend yield N/A
200-day MA $44.66 Market Cap 3.23B

IART Stock Price Chart Interactive Chart >


  • IART scores best on the Value dimension, with a Value rank ahead of 81.9% of US stocks.
  • The strongest trend for IART is in Quality, which has been heading down over the past 177 days.
  • IART ranks lowest in Momentum; there it ranks in the 10th percentile.

IART Stock Summary

  • With a price/earnings ratio of 31.8, INTEGRA LIFESCIENCES HOLDINGS CORP P/E ratio is greater than that of about 75.44% of stocks in our set with positive earnings.
  • Price to trailing twelve month operating cash flow for IART is currently 19.26, higher than 76.06% of US stocks with positive operating cash flow.
  • INTEGRA LIFESCIENCES HOLDINGS CORP's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is 9.82%, greater than the shareholder yield of 82.25% of stocks in our set.
  • If you're looking for stocks that are quantitatively similar to INTEGRA LIFESCIENCES HOLDINGS CORP, a group of peers worth examining would be HUN, ORGO, CW, PLPC, and BRC.
  • Visit IART's SEC page to see the company's official filings. To visit the company's web site, go to

IART Valuation Summary

  • In comparison to the median Healthcare stock, IART's EV/EBIT ratio is 109.45% higher, now standing at 26.6.
  • IART's price/sales ratio has moved down 3.4 over the prior 243 months.

Below are key valuation metrics over time for IART.

Stock Date P/S P/B P/E EV/EBIT
IART 2023-11-20 2.0 1.9 30.0 26.6
IART 2023-11-17 2.0 1.9 30.0 26.6
IART 2023-11-16 2.0 1.9 30.3 26.8
IART 2023-11-15 2.0 1.9 30.5 26.9
IART 2023-11-14 2.0 1.9 30.4 26.8
IART 2023-11-13 1.9 1.8 28.4 25.6

IART Growth Metrics

    Its 2 year price growth rate is now at 21.32%.
  • The 5 year price growth rate now stands at 11.72%.
  • Its year over year revenue growth rate is now at 13.17%.
Over the past 33 months, IART's revenue has gone up $47,611,000.

The table below shows IART's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 1,565.168 248.412 172.988
2022-06-30 1,566.838 262.878 166.302
2022-03-31 1,559.015 287.69 156.582
2021-12-31 1,542.448 312.427 169.075
2021-09-30 1,525.571 323.412 216.435
2021-06-30 1,508.942 310.272 205.543

IART's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • IART has a Quality Grade of C, ranking ahead of 70.12% of graded US stocks.
  • IART's asset turnover comes in at 0.411 -- ranking 114th of 186 Medical Equipment stocks.
  • XENT, ALGN, and CODX are the stocks whose asset turnover ratios are most correlated with IART.

The table below shows IART's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-09-30 0.411 0.614 0.104
2021-06-30 0.416 0.616 0.103
2021-03-31 0.388 0.613 0.086
2020-12-31 0.395 0.620 0.065
2020-09-30 0.406 0.620 0.060
2020-06-30 0.411 0.617 0.030

IART Price Target

For more insight on analysts targets of IART, see our IART price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $77.70 Average Broker Recommendation 1.75 (Moderate Buy)

Integra LifeSciences Holdings Corporation (IART) Company Bio

Integra LifeSciences develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, orthopedics, and general surgery. The company operates in five segments: U.S. Neuro-surgery; U.S. Extremities; U.S. Instruments; U.S. Spine and Other; and International. The company was founded in 1989 and is based in Plainsboro, New Jersey.

IART Latest News Stream

Event/Time News Detail
Loading, please wait...

IART Latest Social Stream

Loading social stream, please wait...

View Full IART Social Stream

Latest IART News From Around the Web

Below are the latest news stories about INTEGRA LIFESCIENCES HOLDINGS CORP that investors may wish to consider to help them evaluate IART as an investment opportunity.

Integra Gains From New Product Launches, Mounting Costs Ail

Integra expands the international reach of the CUSA platform and registers DuraGen, DuraSeal, Mayfield and Duo LED lighting in the EMEA and Latin America.

Yahoo | December 5, 2023

Why Is Glaukos (GKOS) Down 0.4% Since Last Earnings Report?

Glaukos (GKOS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Yahoo | December 1, 2023

Why Is Integra (IART) Up 10.2% Since Last Earnings Report?

Integra (IART) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Yahoo | November 24, 2023

Why Integra LifeSciences Holdings Corporation (NASDAQ:IART) Could Be Worth Watching

Integra LifeSciences Holdings Corporation ( NASDAQ:IART ), is not the largest company out there, but it saw a decent...

Yahoo | November 19, 2023

Integra LifeSciences Holdings Corporation (NASDAQ:IART) Q3 2023 Earnings Call Transcript

Integra LifeSciences Holdings Corporation (NASDAQ:IART) Q3 2023 Earnings Call Transcript October 25, 2023 Integra LifeSciences Holdings Corporation misses on earnings expectations. Reported EPS is $0.76 EPS, expectations were $0.78. Operator: Good day, and thank you for standing by. Welcome to the Integra LifeSciences’ Third Quarter 2023 Financial Results Conference Call. At this time, all participants […]

Yahoo | October 26, 2023

Read More 'IART' Stories Here

IART Price Returns

1-mo 14.13%
3-mo 4.53%
6-mo -0.02%
1-year -26.15%
3-year -30.00%
5-year -17.41%
YTD -26.40%
2022 -16.30%
2021 3.19%
2020 11.39%
2019 29.22%
2018 -5.77%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!